Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02909777
Title Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

Advanced Solid Tumor

lymphoma

diffuse large B-cell lymphoma

Burkitt lymphoma

neuroblastoma

Therapies

CUDC-907

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.